Treatment of Preterm Labour–Inhibition of fetal DNA mediated pro-­‐inflammatory immune responses , Licensing Opportunity from Trinity College Dublin - July 2015 front page preview

Treatment of Preterm Labour–Inhibition of fetal DNA mediated pro-­‐inflammatory immune responses , Licensing Opportunity from Trinity College Dublin - July 2015

We have made the novel discovery that free foetal DNA sparks off an immune reaction in human cells through a receptor called Toll-like Receptor 9 (TLR-9). In our animal model there is a 69% still birth/inflammation from ...

pdf 1.2MB

Novel Anti-Thrombotic Drug Leads Traditional Target: Licensing opportunity from University College Dublin - April 2014 front page preview

Novel Anti-Thrombotic Drug Leads Traditional Target: Licensing opportunity from University College Dublin - April 2014

UCD researchers have developed novel, potent TXA2 receptor/TP antagonists which can be used in patients with general cardiovascular disease at risk of acute coronary syndrome. Evidence from recent large cardiovascular c...

pdf 1.3MB

Chiral Ionic Liquid Solvents - Licensing Opportunity from Dublin City University - April 2014 front page preview

Chiral Ionic Liquid Solvents - Licensing Opportunity from Dublin City University - April 2014

This technology relates to chiral ionic liquids (CILs) which may be used as novel solvents, in particularly for organic synthesis. The CILs have the potential to induce asymmetry into substrates or catalysts in a variety...

pdf 187.8KB